Literature DB >> 10941792

The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development proteins.

T T Tseng1, K S Gratwick, J Kollman, D Park, D H Nies, A Goffeau, M H Saier.   

Abstract

A previous report identified and classified a small family of gram-negative bacterial drug and heavy metal efflux permeases, now commonly referred to as the RND family (TC no. 2.6). We here show that this family is actually a ubiquitous superfamily with representation in all major kingdoms. We report phylogenetic analyses that define seven families within the RND superfamily as follows: (1) the heavy metal efflux (HME) family (gram negative bacteria), (2) the hydrophobe/amphiphile efflux-1 (HAE1) family (gram negative bacteria), (3) the nodulation factor exporter (NFE) family (gram negative bacteria), (4) the SecDF protein-secretion accessory protein (SecDF) family (gram negative and gram positive bacteria as well as archaea), (5) the hydrophobe/amphiphile efflux-2 (HAE2) family (gram positive bacteria), (6) the eukaryotic sterol homeostasis (ESH) family, and (7) the hydrophobe/amphiphile efflux-3 (HAE3) family (archaea and spirochetes). Functionally uncharacterized proteins were identified that are members of the RND superfamily but fall outside of these seven families. Some of the eukaryotic homologues function as enzymes and receptors instead of (or in addition to) transporters. The sizes and topological patterns exhibited by members of all seven families are shown to be strikingly similar, and statistical analyses establish common descent. Multiple alignments of proteins within each family allow derivation of family-specific signature sequences. Structural, functional, mechanistic and evolutionary implication of the reported results are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10941792

Source DB:  PubMed          Journal:  J Mol Microbiol Biotechnol        ISSN: 1464-1801


  230 in total

1.  Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454.

Authors:  S Magnet; P Courvalin; T Lambert
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

Review 2.  Vectorial metabolism and the evolution of transport systems.

Authors:  M H Saier
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

Review 3.  Archaea and their potential role in human disease.

Authors:  Paul B Eckburg; Paul W Lepp; David A Relman
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

Review 4.  Structure and function of efflux pumps that confer resistance to drugs.

Authors:  M Ines Borges-Walmsley; Kenneth S McKeegan; Adrian R Walmsley
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

5.  Sequence and phylogenetic analyses of 4 TMS junctional proteins of animals: connexins, innexins, claudins and occludins.

Authors:  V B Hua; A B Chang; J H Tchieu; N M Kumar; P A Nielsen; M H Saier
Journal:  J Membr Biol       Date:  2003-07-01       Impact factor: 1.843

Review 6.  Extreme secretion: protein translocation across the archael plasma membrane.

Authors:  Gabriela Ring; Jerry Eichler
Journal:  J Bioenerg Biomembr       Date:  2004-02       Impact factor: 2.945

Review 7.  The archaeal Sec-dependent protein translocation pathway.

Authors:  Albert Bolhuis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

Review 8.  Multidrug resistance in bacteria.

Authors:  Hiroshi Nikaido
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli.

Authors:  Julio Ramos Aires; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

10.  Characterization of the Escherichia coli AaeAB efflux pump: a metabolic relief valve?

Authors:  Tina K Van Dyk; Lori J Templeton; Keith A Cantera; Pamela L Sharpe; F Sima Sariaslani
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.